| Dr Dennis T Sugiyama, O D | |
|
1915 W Glenoaks Blvd, Suite 101, Glendale, CA 91201-1541 | |
| (818) 848-4939 | |
| (818) 848-6884 |
| Full Name | Dr Dennis T Sugiyama |
|---|---|
| Gender | Male |
| Speciality | Optometrist |
| Location | 1915 W Glenoaks Blvd, Glendale, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134178155 | NPI | - | NPPES |
| SD0098080 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OPT 9808 TPL (California) | Primary |
| Provider Name | Healthcare Partners Affiliates Medical Group |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1659312593 PECOS PAC ID: 7315842002 Enrollment ID: O20031204001258 |
News Archive
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced positive, top-line proof-of-concept data from its recently completed Phase 2 study in carcinoid syndrome with LX1032, telotristat etiprate. Carcinoid syndrome is a chronic condition caused by neuroendocrine tumors that usually originate from the gastrointestinal tract.
Scientists want to make a chink in the armor of a bacterium that has little name recognition yet is the number-one bacterial cause of the diarrhea, vomiting and stomach pain Americans experience annually.
Spending long periods in space not only leads to muscle atrophy and reductions in bone density, it also has lasting effects on the brain. However, little is known about how different tissues of the brain react to exposure to microgravity, and it remains unclear whether and to what extent the neuroanatomical changes so far observed persist following return to normal gravity.
New findings from nutrition researchers at Washington University School of Medicine in St. Louis suggest that it's not whether body fat is stored in the belly that affects metabolic risk factors for diabetes, high blood triglycerides and cardiovascular disease, but whether it collects in the liver.
Teva Pharmaceutical Industries Ltd. today announced the publication of data from the 15-year clinical study with Copaxone® (glatiramer acetate injection), which is the longest prospective and continuous evaluation ever conducted in relapsing-remitting multiple sclerosis (RRMS) patients. The data were published in the February issue of the journal Multiple Sclerosis.
› Verified 2 days ago
| Provider Name | Mark B Kislinger Md, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1215089594 PECOS PAC ID: 4789745514 Enrollment ID: O20081211000301 |
News Archive
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced positive, top-line proof-of-concept data from its recently completed Phase 2 study in carcinoid syndrome with LX1032, telotristat etiprate. Carcinoid syndrome is a chronic condition caused by neuroendocrine tumors that usually originate from the gastrointestinal tract.
Scientists want to make a chink in the armor of a bacterium that has little name recognition yet is the number-one bacterial cause of the diarrhea, vomiting and stomach pain Americans experience annually.
Spending long periods in space not only leads to muscle atrophy and reductions in bone density, it also has lasting effects on the brain. However, little is known about how different tissues of the brain react to exposure to microgravity, and it remains unclear whether and to what extent the neuroanatomical changes so far observed persist following return to normal gravity.
New findings from nutrition researchers at Washington University School of Medicine in St. Louis suggest that it's not whether body fat is stored in the belly that affects metabolic risk factors for diabetes, high blood triglycerides and cardiovascular disease, but whether it collects in the liver.
Teva Pharmaceutical Industries Ltd. today announced the publication of data from the 15-year clinical study with Copaxone® (glatiramer acetate injection), which is the longest prospective and continuous evaluation ever conducted in relapsing-remitting multiple sclerosis (RRMS) patients. The data were published in the February issue of the journal Multiple Sclerosis.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dennis T Sugiyama, O D 1915 W Glenoaks Blvd, Suite 101, Glendale, CA 91201-1541 Ph: (818) 848-4939 | Dr Dennis T Sugiyama, O D 1915 W Glenoaks Blvd, Suite 101, Glendale, CA 91201-1541 Ph: (818) 848-4939 |
News Archive
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced positive, top-line proof-of-concept data from its recently completed Phase 2 study in carcinoid syndrome with LX1032, telotristat etiprate. Carcinoid syndrome is a chronic condition caused by neuroendocrine tumors that usually originate from the gastrointestinal tract.
Scientists want to make a chink in the armor of a bacterium that has little name recognition yet is the number-one bacterial cause of the diarrhea, vomiting and stomach pain Americans experience annually.
Spending long periods in space not only leads to muscle atrophy and reductions in bone density, it also has lasting effects on the brain. However, little is known about how different tissues of the brain react to exposure to microgravity, and it remains unclear whether and to what extent the neuroanatomical changes so far observed persist following return to normal gravity.
New findings from nutrition researchers at Washington University School of Medicine in St. Louis suggest that it's not whether body fat is stored in the belly that affects metabolic risk factors for diabetes, high blood triglycerides and cardiovascular disease, but whether it collects in the liver.
Teva Pharmaceutical Industries Ltd. today announced the publication of data from the 15-year clinical study with Copaxone® (glatiramer acetate injection), which is the longest prospective and continuous evaluation ever conducted in relapsing-remitting multiple sclerosis (RRMS) patients. The data were published in the February issue of the journal Multiple Sclerosis.
› Verified 2 days ago
John J. Mielke, O.d. Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 801 S Chevy Chase Dr Ste 100, Glendale, CA 91205 Phone: 818-956-8785 Fax: 818-956-5367 | |
Dr. Megan Quan, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 409 N Central Ave, Glendale, CA 91203 Phone: 818-265-7755 | |
Dr. Movses D'janbatian, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 330 N Brand Blvd, Suite 110, Glendale, CA 91203 Phone: 818-241-4921 Fax: 818-241-0468 | |
Jewel City Optometry Optometrist Medicare: Medicare Enrolled Practice Location: 839 N Glendale Ave, Glendale, CA 91206 Phone: 818-240-3937 Fax: 818-240-3933 | |
Ida Simonyan, OD Optometrist Medicare: Medicare Enrolled Practice Location: 330 N Brand Blvd Ste 110, Glendale, CA 91203 Phone: 708-423-1515 | |
Dr. Movses D'janbatian, Od, Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 330 N Brand Blvd, Suite 110, Glendale, CA 91203 Phone: 818-241-4921 Fax: 818-241-0468 | |
Dr. Betty Wai-han Lee-villanueva, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 330 N Brand Blvd, Suite 110, Glendale, CA 91203 Phone: 866-260-2020 |